Unique Challenges

A payment model that works for gene therapy

We understand that covering gene therapy can be challenging for employers and payers. The ultra high price tag, lightning strike nature, and limited data on efficacy all pose unique challenges. Our payment model solves for these challenges - eliminating budgeting risk, linking cost to value, and providing an affordable access option for payers to ensure patient access.